CNMD
$54.41
Revenue | $342.35Mn |
Net Profits | $21.42Mn |
Net Profit Margins | 6.26% |
Conmed Corp’s revenue jumped 3.51% since last year same period to $342.35Mn in the Q2 2025. On a quarterly growth basis, Conmed Corp has generated 6.56% jump in its revenue since last 3-months.
Conmed Corp’s net profit fell -28.54% since last year same period to $21.42Mn in the Q2 2025. On a quarterly growth basis, Conmed Corp has generated 254.89% jump in its net profits since last 3-months.
Conmed Corp’s net profit margin fell -30.96% since last year same period to 6.26% in the Q2 2025. On a quarterly growth basis, Conmed Corp has generated 233.03% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.05 |
EPS Estimate Current Year | 1.05 |
Conmed Corp’s earning per share (EPS) estimates for the current quarter stand at 1.05 - a -5.41% fall from last quarter’s estimates.
Conmed Corp’s earning per share (EPS) estimates for the current year stand at 1.05.
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.2 |
Conmed Corp’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Conmed Corp has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Conmed Corp declared 0.2 dividend per share during the earnings announcement for Q3 2025.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-01 | 0.81 | 0.95 | 17.05% |
2025-10-22 | 1.05 | 0 | -100% |
2025-07-31 | 1.11 | 1.15 | 3.6% |